In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vertex: Preparing to Go Commercial

Executive Summary

With perhaps little over a year to go before it files its NDA for hepatitis C hopeful telaprevir, Vertex is gearing up for its transition to a commercially focused company. New CEO Matt Emmens talks to IN VIVO about the financial and cultural challenges of building a commercial organization to match Vertex's highly productive R&D.
Advertisement

Related Content

Hepatitis C Marketing: Applying Primary Care Tactics To Specialty Products
Hepatitis C Marketing: Applying Primary Care Tactics To Specialty Products
Best of the Blog: IN VIVO, September 2009
In HCV, Protease Race Heats Up with Combo Therapy Looming
Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way
Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way
Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
Vertex: Sticking To Its Story
Vertex Sells Productivity

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel